257 related articles for article (PubMed ID: 29934276)
1. Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA-Enhanced Magnetic Resonance Images.
Jung J; Kim H; Yoon SM; Cho B; Kim YJ; Kwak J; Kim JH
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):867-874. PubMed ID: 29934276
[TBL] [Abstract][Full Text] [Related]
2. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
Jung J; Yoon SM; Cho B; Choi YE; Kwak J; Kim SY; Lee SW; Ahn SD; Choi EK; Kim JH
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):96-101. PubMed ID: 26503671
[TBL] [Abstract][Full Text] [Related]
3. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
4. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced Liver Injury after 3D-conformal Radiotherapy for Hepatocellular Carcinoma: Quantitative Assessment Using Gd-EOB-DTPA-enhanced MRI.
Fukugawa Y; Namimoto T; Toya R; Saito T; Yuki H; Matsuyama T; Ikeda O; Yamashita Y; Oya N
Acta Med Okayama; 2017 Feb; 71(1):25-29. PubMed ID: 28238007
[TBL] [Abstract][Full Text] [Related]
6. Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.
Sanuki N; Takeda A; Oku Y; Eriguchi T; Nishimura S; Aoki Y; Mizuno T; Iwabuchi S; Kunieda E
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):306-11. PubMed ID: 24411601
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
Takamatsu S; Yamamoto K; Maeda Y; Kawamura M; Shibata S; Sato Y; Terashima K; Shimizu Y; Tameshige Y; Sasaki M; Asahi S; Kondou T; Kobayashi S; Matsui O; Gabata T
PLoS One; 2016; 11(12):e0167155. PubMed ID: 27907063
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
9. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma.
Nakamura Y; Kimura T; Higaki T; Honda Y; Komoto D; Yamagami T; Iida M; Nagata Y; Honda Y; Aikata H; Chayama K; Awai K
Jpn J Radiol; 2015 Oct; 33(10):627-35. PubMed ID: 26227061
[TBL] [Abstract][Full Text] [Related]
11. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
12. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
[TBL] [Abstract][Full Text] [Related]
13. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
14. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB- DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma.
Nakamura S; Nouso K; Kobayashi Y; Shiraha H; Ohnishi H; Toshimori J; Kuwaki K; Hagihara H; Takayama H; Yamamoto K
Acta Med Okayama; 2013; 67(4):239-44. PubMed ID: 23970322
[TBL] [Abstract][Full Text] [Related]
17. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
18. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of breath-hold inversion recovery-prepared T1-weighted two-dimensional gradient echo sequence for detection of hepatocellular carcinoma in Gd-EOB-DTPA-enhanced MR imaging.
Ohno T; Isoda H; Furuta A; Arizono S; Yamashita R; Ono A; Togashi K
Clin Imaging; 2016; 40(5):997-1003. PubMed ID: 27295329
[TBL] [Abstract][Full Text] [Related]
20. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
